These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3980316)

  • 1. Clavulanic acid/antibiotic ratios.
    Rolinson GN
    J Antimicrob Chemother; 1985 Feb; 15(2):256-7. PubMed ID: 3980316
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
    Holder IA; Vanderpool L; Wesselman J
    J Burn Care Rehabil; 1985; 6(4):331-4. PubMed ID: 3879938
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity of clinical bacterial isolates to Timentin (ticarcillin/clavulanic acid).
    Villiger JW
    N Z Med J; 1986 Nov; 99(814):914. PubMed ID: 3492692
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis.
    Bowie WR
    Antimicrob Agents Chemother; 1986 Apr; 29(4):713-5. PubMed ID: 3707116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of timentin.
    Thomas MG; Lang SD
    N Z Med J; 1985 May; 98(779):403-4. PubMed ID: 3857527
    [No Abstract]   [Full Text] [Related]  

  • 6. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
    White AR; Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and disk susceptibility of Timentin: current status.
    Fuchs PC; Barry AL; Jones RN
    Am J Med; 1985 Nov; 79(5B):25-32. PubMed ID: 4073092
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C; Kitzis M; Le Mée J
    Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
    Barry AL; Ayers LW; Gavan TL; Gerlach EH; Jones RN
    Eur J Clin Microbiol; 1984 Jun; 3(3):203-6. PubMed ID: 6147246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP
    Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative aminoglycoside inactivation by potassium clavulanate.
    Courcol RJ; Martin GR
    J Antimicrob Chemother; 1986 May; 17(5):682-4. PubMed ID: 3722038
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid.
    Gould IM; Dent J; Wise R
    J Antimicrob Chemother; 1987 Mar; 19(3):307-12. PubMed ID: 3106304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility testing recommendations for ticarcillin/clavulanic acid in the Stokes' disc diffusion test.
    Sutherland R
    J Antimicrob Chemother; 1989 Sep; 24(3):463-4. PubMed ID: 2808198
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential sensitivities to amoxycillin/clavulanate and amoxycillin in general practice urinary infections.
    Brumfitt W; Hamilton-Miller JM
    Lancet; 1983 Sep; 2(8349):566. PubMed ID: 6136712
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid.
    Wong CS; Palmer GS; Cynamon MH
    J Antimicrob Chemother; 1988 Dec; 22(6):863-6. PubMed ID: 3149633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
    Bourgault AM; Lamothe F
    J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of parenteral ticarcillin formulated with clavulanic acid: Timentin.
    Staniforth DH; Coates PE; Davies BE; Horton R
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):123-9. PubMed ID: 3699938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of piperacillin v timentin and ticarcillin.
    Bremner DA
    N Z Med J; 1987 May; 100(823):299-300. PubMed ID: 3138579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.